ADAIR

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameADAIR
Drug Alias NameAmphetamine oralAbuse-Deterrent
ClassificationSmall molecules
Mechanisms of ActionCentral nervous system stimulantsTrace amine-associated receptor 1 agonists
TargetsTrace amine-associated receptor 1
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityNarcolepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVallon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVallon Pharmaceuticals IncAardvark Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityNarcolepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A